Previous Page  5 / 11 Next Page
Information
Show Menu
Previous Page 5 / 11 Next Page
Page Background

allied

academies

Page 17

Allied J Med Res 2017

Volume 1 Issue 2

September 01-02, 2017 London, UK

3

rd

International Conference and Expo on

Herbal & Alternative Medicine

Herbal Medicine 2017

Oroma Nwanodi

Locum Tenens, USA

Oroma Nwanodi, Allied J Med Res 2017

Nutraceuticals:NongynecologicCancer

ChemoradiationSensitizers, Chemopreventives

andAdverse Effect Resolvers

N

utraceutical chemoradiation sensitization can

reduce conventional chemoradiation dosing, in

turn reducing conventional chemoradiation adverse

effects, while maintaining chemoradiation therapeutic

effectiveness. Nutraceuticals also prevent and treat

chemoradiation adverse effects from anxiety and

depression through xerostomia. Improved quality

of life motivates up to 75% of integrative oncology

users. Nutraceutical chemoprevention should

motivate everyone towards healthy diet consumption.

Diindolymethane and indole-3-carbinol can sensitize

pancreatic cancer to conventional chemotherapy.

Sulforaphane chemosensitizes arsenic trioxide,

doxorubicin, and gemcitabine. Turmeric is synergistic

with docetaxel in lung cancer treatment. Inositol

hexakisphosphate chemosensitizes for irinotecan

colon cancer therapy. Withaferin A is synergistic

with doxorubicin. Curcumin radiosensitizes prostate

cancer, polyunsaturated fatty acids radiosensitize

renal cancers, and sulforaphane radiosensitizes

head and neck cancers. Some Ferula species

derived monoterpenes independently reverse

multidrug resistance via p-glycoprotein inhibition.

Other Ferula species derived montoerpenes need

synergism with vinblastine to reverse multidrug

resistance. Fermented nutraceuticals may offer

additional micro-organism derived chemopreventive

properties. Diets can now be targeted against a

given type of cancer. Individual nutraceuticals

such as rice bran possess multiple encompassing

chemopreventive mechanisms of action: anti-

oxidation, anti-proliferation/pro-apoptosis, immune

modulation, and mucosal protection. Chemoradiation

sensitization equivalence, anti-angiogenesis, and

immune modulation are a few areas for future

research. Chemopreventive dietary research can

explore the quality of consumed products in addition

to component portions. Nutraceutical chemoradiation

sensitization has the potential to positively affect

most cancer patients.

Biography

Oroma Nwanodi graduated from Meharry Medical College of Nashville,

Tennessee in USA as a Medical Doctor in 2001. She specialized in Obstetrics

and Gynecology at The University of Massachussets and Maimonides Medical

Center. In 2013 and 2014, she obtained specialization in Integrative Holistic

Medicine. In 2016, she completed the Doctor of Health Science program at

A T Still University, Mesa, Arizona. She has practiced in California, Missouri,

Minnesota, and Wyoming. She has published more than 25 papers in reputed

journals and serves as an Editorial Board Member for several journals.

o.nwanodi@juno.com